FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045175521> ?p ?o ?g. }

• W2045175521 endingPage "288" @default.
• W2045175521 startingPage "280" @default.
• W2045175521 abstract "To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy premenopausal women. The subsequent analysis of steroids in both serum and urine during the test was carried out at several time points for up to 24 h. Serum levels of 17 alpha-hydroxyprogesterone were elevated at all time points of the test in PCOS patients vs. controls [at baseline, 3.5 +/- 0.2 vs. 1.8 +/- 0.1 nmol/L (P < 0.001); at 24 h, 9.9 +/- 0.9 vs. 4.9 +/- 0.3 nmol/L (P < 0.001)]. Basal levels of androstenedione were higher in the patient group, but there was no significant change during the test in either group. Serum testosterone levels were also found to differ in PCOS patients compared with the control values at baseline (2.2 +/- 0.2 vs. 1.5 +/- 0.1 nmol/L; P < 0.05) and after nafarelin treatment (at 24 h, 3.2 +/- 0.4 vs. 1.8 +/- 0.2 nmol/L; P < 0.05). Serum estradiol levels rose significantly in both groups during the test; the posttest levels were significantly higher in PCOS than in controls. The PCOS patients displayed a significant increase in androgen and gestagen metabolites as well as in glucocorticoid metabolites excreted in the urine during the 24 h. In the control subjects, except for 17 alpha-hydroxypregnanolone, which rose significantly, none of the urinary steroids investigated showed relevant changes during the nafarelin test. The posttest excretion of allo-tetrahydrocortisol (1.4 +/- 0.2 vs. 0.3 +/- 0.1 mumol/g creatinine; P < 0.001) and the increase in 17 alpha-hydroxypregnanolone excretion (1.4 +/- 0.2 vs. 0.3 +/- 0.1 mumol/g creatinine; P < 0.001) were distinctly higher in PCOS patients than in the controls; the diagnostic sensitivity of the combination of both parameters was 89% at a 93% specificity. Thus, measurements of 17 alpha-hydroxyprogesterone levels in serum and of urinary allo-tetrahydrocortisol and 17 alpha-hydroxypregnanolone after nafarelin treatment make this stimulation test a valuable diagnostic tool for identifying PCOS patients. The significant changes in the excretion of urinary androgen and gestagen metabolites, unmasked by GnRH agonist stimulation, suggest a functional alteration of the pituitary-ovarian axis. The reason for the increased excretion of glucocorticoid metabolites after nafarelin stimulation remains to be clarified." @default.
• W2045175521 created "2016-06-24" @default.
• W2045175521 creator A5007554920 @default.
• W2045175521 creator A5007769906 @default.
• W2045175521 creator A5027726469 @default.
• W2045175521 creator A5033504949 @default.
• W2045175521 creator A5037937718 @default.
• W2045175521 creator A5041139862 @default.
• W2045175521 creator A5052434013 @default.
• W2045175521 creator A5052604618 @default.
• W2045175521 creator A5063830479 @default.
• W2045175521 date "1995-01-01" @default.
• W2045175521 modified "2023-10-16" @default.
• W2045175521 title "Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion." @default.
• W2045175521 cites W122525300 @default.
• W2045175521 cites W1968003395 @default.
• W2045175521 cites W1989689562 @default.
• W2045175521 cites W1989700537 @default.
• W2045175521 cites W1993061903 @default.
• W2045175521 cites W2001457778 @default.
• W2045175521 cites W2003517642 @default.
• W2045175521 cites W2013495676 @default.
• W2045175521 cites W2015526883 @default.
• W2045175521 cites W2030618927 @default.
• W2045175521 cites W2031566801 @default.
• W2045175521 cites W2035004241 @default.
• W2045175521 cites W2039709079 @default.
• W2045175521 cites W2040502152 @default.
• W2045175521 cites W2041196630 @default.
• W2045175521 cites W2041754562 @default.
• W2045175521 cites W2044426380 @default.
• W2045175521 cites W2054791621 @default.
• W2045175521 cites W2057031337 @default.
• W2045175521 cites W2064143069 @default.
• W2045175521 cites W2064608831 @default.
• W2045175521 cites W2066433755 @default.
• W2045175521 cites W2074320591 @default.
• W2045175521 cites W2076471628 @default.
• W2045175521 cites W2096677248 @default.
• W2045175521 cites W2106378688 @default.
• W2045175521 cites W2117543484 @default.
• W2045175521 cites W2128224630 @default.
• W2045175521 cites W2155995048 @default.
• W2045175521 cites W2236668654 @default.
• W2045175521 cites W2316958484 @default.
• W2045175521 cites W2396953888 @default.
• W2045175521 cites W2402031162 @default.
• W2045175521 cites W2418770054 @default.
• W2045175521 cites W2460565047 @default.
• W2045175521 doi "https://doi.org/10.1210/jcem.80.1.7829627" @default.
• W2045175521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7829627" @default.
• W2045175521 hasPublicationYear "1995" @default.
• W2045175521 type Work @default.
• W2045175521 sameAs 2045175521 @default.
• W2045175521 citedByCount "11" @default.
• W2045175521 crossrefType "journal-article" @default.
• W2045175521 hasAuthorship W2045175521A5007554920 @default.
• W2045175521 hasAuthorship W2045175521A5007769906 @default.
• W2045175521 hasAuthorship W2045175521A5027726469 @default.
• W2045175521 hasAuthorship W2045175521A5033504949 @default.
• W2045175521 hasAuthorship W2045175521A5037937718 @default.
• W2045175521 hasAuthorship W2045175521A5041139862 @default.
• W2045175521 hasAuthorship W2045175521A5052434013 @default.
• W2045175521 hasAuthorship W2045175521A5052604618 @default.
• W2045175521 hasAuthorship W2045175521A5063830479 @default.
• W2045175521 hasBestOaLocation W20451755212 @default.
• W2045175521 hasConcept C10146269 @default.
• W2045175521 hasConcept C126322002 @default.
• W2045175521 hasConcept C134018914 @default.
• W2045175521 hasConcept C2776683971 @default.
• W2045175521 hasConcept C2777391703 @default.
• W2045175521 hasConcept C2777911890 @default.
• W2045175521 hasConcept C2778024521 @default.
• W2045175521 hasConcept C2779279991 @default.
• W2045175521 hasConcept C2779306644 @default.
• W2045175521 hasConcept C2780026642 @default.
• W2045175521 hasConcept C2780186808 @default.
• W2045175521 hasConcept C3018442814 @default.
• W2045175521 hasConcept C71315377 @default.
• W2045175521 hasConcept C71924100 @default.
• W2045175521 hasConcept C77411442 @default.
• W2045175521 hasConceptScore W2045175521C10146269 @default.
• W2045175521 hasConceptScore W2045175521C126322002 @default.
• W2045175521 hasConceptScore W2045175521C134018914 @default.
• W2045175521 hasConceptScore W2045175521C2776683971 @default.
• W2045175521 hasConceptScore W2045175521C2777391703 @default.
• W2045175521 hasConceptScore W2045175521C2777911890 @default.
• W2045175521 hasConceptScore W2045175521C2778024521 @default.
• W2045175521 hasConceptScore W2045175521C2779279991 @default.
• W2045175521 hasConceptScore W2045175521C2779306644 @default.
• W2045175521 hasConceptScore W2045175521C2780026642 @default.
• W2045175521 hasConceptScore W2045175521C2780186808 @default.
• W2045175521 hasConceptScore W2045175521C3018442814 @default.
• W2045175521 hasConceptScore W2045175521C71315377 @default.
• W2045175521 hasConceptScore W2045175521C71924100 @default.
• W2045175521 hasConceptScore W2045175521C77411442 @default.
• W2045175521 hasIssue "1" @default.
• W2045175521 hasLocation W20451755211 @default.

• next